These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10563766)

  • 1. Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds.
    Lee LS; Conover C; Shi C; Whitlow M; Filpula D
    Bioconjug Chem; 1999; 10(6):973-81. PubMed ID: 10563766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of site-specific ScFv PEGylation for tumor-targeting pharmaceuticals.
    Natarajan A; Xiong CY; Albrecht H; DeNardo GL; DeNardo SJ
    Bioconjug Chem; 2005; 16(1):113-21. PubMed ID: 15656582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallization of single-chain Fv proteins.
    Essig NZ; Wood JF; Howard AJ; Raag R; Whitlow M
    J Mol Biol; 1993 Dec; 234(3):897-901. PubMed ID: 8254684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailoring structure-function and pharmacokinetic properties of single-chain Fv proteins by site-specific PEGylation.
    Yang K; Basu A; Wang M; Chintala R; Hsieh MC; Liu S; Hua J; Zhang Z; Zhou J; Li M; Phyu H; Petti G; Mendez M; Janjua H; Peng P; Longley C; Borowski V; Mehlig M; Filpula D
    Protein Eng; 2003 Oct; 16(10):761-70. PubMed ID: 14600206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-chain Fv with manifold N-glycans as bifunctional scaffolds for immunomolecules.
    Wang M; Lee LS; Nepomich A; Yang JD; Conover C; Whitlow M; Filpula D
    Protein Eng; 1998 Dec; 11(12):1277-83. PubMed ID: 9930678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactoferrin conjugated with 40-kDa branched poly(ethylene glycol) has an improved circulating half-life.
    Nojima Y; Suzuki Y; Yoshida K; Abe F; Shiga T; Takeuchi T; Sugiyama A; Shimizu H; Sato A
    Pharm Res; 2009 Sep; 26(9):2125-32. PubMed ID: 19554429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability.
    Whitlow M; Bell BA; Feng SL; Filpula D; Hardman KD; Hubert SL; Rollence ML; Wood JF; Schott ME; Milenic DE
    Protein Eng; 1993 Nov; 6(8):989-95. PubMed ID: 8309948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility.
    Albrecht H; Denardo GL; Denardo SJ
    J Immunol Methods; 2006 Mar; 310(1-2):100-16. PubMed ID: 16499921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
    Milenic DE; Yokota T; Filpula DR; Finkelman MA; Dodd SW; Wood JF; Whitlow M; Snoy P; Schlom J
    Cancer Res; 1991 Dec; 51(23 Pt 1):6363-71. PubMed ID: 1933899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Recombinant Methioninase for Cancer Treatment.
    Hoffman RM; Tan Y; Li S; Han Q; Yagi S; Takakura T; Takimoto A; Inagaki K; Kudou D
    Methods Mol Biol; 2019; 1866():107-131. PubMed ID: 30725412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administration.
    Adams GP; McCartney JE; Wolf EJ; Eisenberg J; Tai MS; Huston JS; Stafford WF; Bookman MA; Houston LL; Weiner LM
    Cancer Immunol Immunother; 1995 May; 40(5):299-306. PubMed ID: 7600561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.
    George AJ; Jamar F; Tai MS; Heelan BT; Adams GP; McCartney JE; Houston LL; Weiner LM; Oppermann H; Peters AM
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8358-62. PubMed ID: 7667295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides.
    McCartney JE; Tai MS; Hudziak RM; Adams GP; Weiner LM; Jin D; Stafford WF; Liu S; Bookman MA; Laminet AA
    Protein Eng; 1995 Mar; 8(3):301-14. PubMed ID: 7479692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugation of PolyPEG to interferon alpha extends serum half-life while maintaining low viscosity of the conjugate.
    Podobnik B; Helk B; Smilović V; Škrajnar Š; Fidler K; Jevševar S; Godwin A; Williams P
    Bioconjug Chem; 2015 Mar; 26(3):452-9. PubMed ID: 25629733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.
    Danial M; van Dulmen TH; Aleksandrowicz J; Pötgens AJ; Klok HA
    Bioconjug Chem; 2012 Aug; 23(8):1648-60. PubMed ID: 22770564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and enzymatic site specific PEGylation of hGH.
    da Silva Freitas D; Mero A; Pasut G
    Bioconjug Chem; 2013 Mar; 24(3):456-63. PubMed ID: 23432141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylation and HAylation via catechol: α-Amine-specific reaction at N-terminus of peptides and proteins.
    Song IT; Lee M; Lee H; Han J; Jang JH; Lee MS; Koh GY; Lee H
    Acta Biomater; 2016 Oct; 43():50-60. PubMed ID: 27424082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical applications of single-chain antibodies.
    Huston JS; McCartney J; Tai MS; Mottola-Hartshorn C; Jin D; Warren F; Keck P; Oppermann H
    Int Rev Immunol; 1993; 10(2-3):195-217. PubMed ID: 8360586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.